- Home
- ETON vs LOCO Comparison
ETON vs LOCO Comparison
Compare ETON & LOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ETON | LOCO |
|---|---|---|
| Founded | 2017 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.9M | 331.3M |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ETON | LOCO |
|---|---|---|
| Price | $17.61 | $11.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $31.00 | $14.50 |
| AVG Volume (30 Days) | ★ 293.3K | 150.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.22 |
| EPS | N/A | ★ 0.68 |
| Revenue | $39,011,000.00 | ★ $401,701,000.00 |
| Revenue This Year | $107.23 | $5.42 |
| Revenue Next Year | $29.72 | $1.67 |
| P/E Ratio | ★ N/A | $16.41 |
| Revenue Growth | ★ 23.29 | 5.68 |
| 52 Week Low | $11.09 | $8.29 |
| 52 Week High | $23.00 | $11.74 |
Technical Indicators
Market Signals| Indicator | ETON | LOCO |
|---|---|---|
| Relative Strength Index (RSI) | 57.35 | 60.29 |
| Support Level | $17.38 | $10.16 |
| Resistance Level | $20.35 | $11.38 |
| Average True Range (ATR) | 1.06 | 0.28 |
| MACD | 0.03 | 0.06 |
| Stochastic Oscillator | 41.19 | 94.63 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About LOCO El Pollo Loco Holdings Inc.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. Restaurant locations are typically free-standing and include drive-thrus, and menus include many low-priced options. Poultry is the company's largest food cost, accounting for roughly 38% of total food and paper cost, and the company manages that commodity price risk by using multiple suppliers and entering supply contracts of varying lengths depending on market conditions.